Mrs Vatina Lynn Gifford, LPN | |
212 Blue Ball Ave, Elkton, MD 21921-5222 | |
(410) 287-2949 | |
Not Available |
Full Name | Mrs Vatina Lynn Gifford |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 212 Blue Ball Ave, Elkton, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902024250 | NPI | - | NPPES |
LP24313 | Other | MD | NURSING LICENSURE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | LP24313 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Vatina Lynn Gifford, LPN 212 Blue Ball Ave, Elkton, MD 21921-5222 Ph: (410) 287-2949 | Mrs Vatina Lynn Gifford, LPN 212 Blue Ball Ave, Elkton, MD 21921-5222 Ph: (410) 287-2949 |
News Archive
New research may help explain why hundreds of thousands of Americans a year get sick - and tens of thousands die - after bacteria get into their blood. It also suggests why some of those bloodstream infections resist treatment with even the most powerful antibiotics.
Smoking has been linked to a higher risk of bone fractures. Researchers have now identified certain lung-related factors that may help to predict an individual smoker's fracture risk.
Graceway Pharmaceuticals announced today that the Food and Drug Administration has approved Zyclara Cream for the treatment of external genital and perianal warts in patients 12 years of age and older.
RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the strategic corporate venture fund of Merck Serono, and Aravis SA.
› Verified 8 days ago